Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CMCSA vs GSK✓SelectedUSD · GSKCMCSA vs GSK performance historyLatest closeAs of-1.51%11/19
Stock and ETF performance explorer

CMCSA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-39.2%
GSK return
+39.6%
Excess return
-78.7%
Maximum drawdown
-49.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.5%-1.6%+0.1%-1.2%
7D+0.2%-4.7%+5.0%+1.1%
30D+11.2%-4.7%+15.9%+12.1%
3M-5.1%-8.8%+3.7%-3.6%
6M+3.2%-4.6%+7.8%+4.0%
YTD-6.5%+1.0%-7.5%-6.5%
1Y+4.0%+6.9%-2.9%+3.2%
3Y-29.6%+52.5%-82.1%-34.6%
5Y-39.2%+40.3%-79.5%-43.4%
All-39.2%+39.6%-78.7%-43.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling